Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-07

FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA-approved Lupin Pharmaceuticals' supplemental application for a Telmisartan and Amlodipine fixed-dose combination, enabling the generic product to be markete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Amlodipine (Telmisartan and Amlodipine)

Snippet

SUPPL AP for TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)